0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Avian Influenza Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: March 2025
|
Report Code: QYRE-Auto-11161
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Avian Influenza Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Avian Influenza Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-11161
Report
March 2025
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Avian Influenza Vaccines Sales Market Size

The global Avian Influenza Vaccines market size was US$ 1100 million in 2024 and is forecast to a readjusted size of US$ 1592 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.

Avian Influenza Vaccines Sales Market

Avian Influenza Vaccines Sales Market

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
The global Avian Influenza Vaccines market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Avian Influenza Vaccines Sales Market Report

Report Metric Details
Report Name Avian Influenza Vaccines Sales Market
Forecasted market size in 2031 US$ 1592 million
CAGR 5.5%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Chicken
  • Duck & Goose
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, Sindh Poultry Vaccine Centre, Merck Animal Health, PT Medion Farma Jaya, Avimex Animal Health, JOVAC, Bio-Labs, Pusvetma, IPB-Shigeta, Medion Farma Jaya, Caprifamarindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Avian Influenza Vaccines market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., H9 Avian Influenza Vaccines in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Duck & Goose in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
  • - Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
  • - Product Portfolio Optimization: Align offerings with regional preferences (e.g., H5+H7 Avian Influenza Vaccines dominance in Europe vs. H9 Avian Influenza Vaccines demand in MEA).
  • - Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Avian Influenza Vaccines Sales Market size in 2031?

Ans: The Avian Influenza Vaccines Sales Market size in 2031 will be US$ 1592 million.

What is the market share of major companies in Avian Influenza Vaccines Sales Market?

Ans: Global top five manufacturers hold a share over 70%.

What is the Avian Influenza Vaccines Sales Market share by region?

Ans: China is the largest market, with a share about 45%.

Who are the main players in the Avian Influenza Vaccines Sales Market report?

Ans: The main players in the Avian Influenza Vaccines Sales Market are Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, Sindh Poultry Vaccine Centre, Merck Animal Health, PT Medion Farma Jaya, Avimex Animal Health, JOVAC, Bio-Labs, Pusvetma, IPB-Shigeta, Medion Farma Jaya, Caprifamarindo

What are the Application segmentation covered in the Avian Influenza Vaccines Sales Market report?

Ans: The Applications covered in the Avian Influenza Vaccines Sales Market report are Chicken, Duck & Goose, Other

What are the Type segmentation covered in the Avian Influenza Vaccines Sales Market report?

Ans: The Types covered in the Avian Influenza Vaccines Sales Market report are H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines

1 Market Overview
1.1 Avian Influenza Vaccines Product Scope
1.2 Avian Influenza Vaccines by Type
1.2.1 Global Avian Influenza Vaccines Sales by Type (2020 & 2024 & 2031)
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Avian Influenza Vaccines by Application
1.3.1 Global Avian Influenza Vaccines Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Avian Influenza Vaccines Market Estimates and Forecasts (2020-2031)
1.4.1 Global Avian Influenza Vaccines Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Avian Influenza Vaccines Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Avian Influenza Vaccines Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Avian Influenza Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Avian Influenza Vaccines Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Avian Influenza Vaccines Sales Market Share by Region (2020-2025)
2.2.2 Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2025)
2.3 Global Avian Influenza Vaccines Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Avian Influenza Vaccines Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Avian Influenza Vaccines Market Size and Prospective (2020-2031)
2.4.2 Europe Avian Influenza Vaccines Market Size and Prospective (2020-2031)
2.4.3 China Avian Influenza Vaccines Market Size and Prospective (2020-2031)
2.4.4 Japan Avian Influenza Vaccines Market Size and Prospective (2020-2031)
2.4.5 South Korea Avian Influenza Vaccines Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Avian Influenza Vaccines Historic Market Review by Type (2020-2025)
3.1.1 Global Avian Influenza Vaccines Sales by Type (2020-2025)
3.1.2 Global Avian Influenza Vaccines Revenue by Type (2020-2025)
3.1.3 Global Avian Influenza Vaccines Price by Type (2020-2025)
3.2 Global Avian Influenza Vaccines Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Avian Influenza Vaccines Sales Forecast by Type (2026-2031)
3.2.2 Global Avian Influenza Vaccines Revenue Forecast by Type (2026-2031)
3.2.3 Global Avian Influenza Vaccines Price Forecast by Type (2026-2031)
3.3 Different Types Avian Influenza Vaccines Representative Players
4 Global Market Size by Application
4.1 Global Avian Influenza Vaccines Historic Market Review by Application (2020-2025)
4.1.1 Global Avian Influenza Vaccines Sales by Application (2020-2025)
4.1.2 Global Avian Influenza Vaccines Revenue by Application (2020-2025)
4.1.3 Global Avian Influenza Vaccines Price by Application (2020-2025)
4.2 Global Avian Influenza Vaccines Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Avian Influenza Vaccines Sales Forecast by Application (2026-2031)
4.2.2 Global Avian Influenza Vaccines Revenue Forecast by Application (2026-2031)
4.2.3 Global Avian Influenza Vaccines Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Avian Influenza Vaccines Application
5 Competition Landscape by Players
5.1 Global Avian Influenza Vaccines Sales by Players (2020-2025)
5.2 Global Top Avian Influenza Vaccines Players by Revenue (2020-2025)
5.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
5.4 Global Avian Influenza Vaccines Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Avian Influenza Vaccines, Product Type & Application
5.7 Global Key Manufacturers of Avian Influenza Vaccines, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Avian Influenza Vaccines Sales by Company
6.1.1.1 North America Avian Influenza Vaccines Sales by Company (2020-2025)
6.1.1.2 North America Avian Influenza Vaccines Revenue by Company (2020-2025)
6.1.2 North America Avian Influenza Vaccines Sales Breakdown by Type (2020-2025)
6.1.3 North America Avian Influenza Vaccines Sales Breakdown by Application (2020-2025)
6.1.4 North America Avian Influenza Vaccines Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Avian Influenza Vaccines Sales by Company
6.2.1.1 Europe Avian Influenza Vaccines Sales by Company (2020-2025)
6.2.1.2 Europe Avian Influenza Vaccines Revenue by Company (2020-2025)
6.2.2 Europe Avian Influenza Vaccines Sales Breakdown by Type (2020-2025)
6.2.3 Europe Avian Influenza Vaccines Sales Breakdown by Application (2020-2025)
6.2.4 Europe Avian Influenza Vaccines Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Avian Influenza Vaccines Sales by Company
6.3.1.1 China Avian Influenza Vaccines Sales by Company (2020-2025)
6.3.1.2 China Avian Influenza Vaccines Revenue by Company (2020-2025)
6.3.2 China Avian Influenza Vaccines Sales Breakdown by Type (2020-2025)
6.3.3 China Avian Influenza Vaccines Sales Breakdown by Application (2020-2025)
6.3.4 China Avian Influenza Vaccines Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Avian Influenza Vaccines Sales by Company
6.4.1.1 Japan Avian Influenza Vaccines Sales by Company (2020-2025)
6.4.1.2 Japan Avian Influenza Vaccines Revenue by Company (2020-2025)
6.4.2 Japan Avian Influenza Vaccines Sales Breakdown by Type (2020-2025)
6.4.3 Japan Avian Influenza Vaccines Sales Breakdown by Application (2020-2025)
6.4.4 Japan Avian Influenza Vaccines Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments, Downstream and Major Customers
6.5.1 South Korea Avian Influenza Vaccines Sales by Company
6.5.1.1 South Korea Avian Influenza Vaccines Sales by Company (2020-2025)
6.5.1.2 South Korea Avian Influenza Vaccines Revenue by Company (2020-2025)
6.5.2 South Korea Avian Influenza Vaccines Sales Breakdown by Type (2020-2025)
6.5.3 South Korea Avian Influenza Vaccines Sales Breakdown by Application (2020-2025)
6.5.4 South Korea Avian Influenza Vaccines Major Customer
6.5.5 South Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Information
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Boehringer Ingelheim Avian Influenza Vaccines Products Offered
7.1.5 Boehringer Ingelheim Recent Development
7.2 CAHIC
7.2.1 CAHIC Company Information
7.2.2 CAHIC Business Overview
7.2.3 CAHIC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CAHIC Avian Influenza Vaccines Products Offered
7.2.5 CAHIC Recent Development
7.3 DHN
7.3.1 DHN Company Information
7.3.2 DHN Business Overview
7.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.3.4 DHN Avian Influenza Vaccines Products Offered
7.3.5 DHN Recent Development
7.4 HVRI
7.4.1 HVRI Company Information
7.4.2 HVRI Business Overview
7.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.4.4 HVRI Avian Influenza Vaccines Products Offered
7.4.5 HVRI Recent Development
7.5 CEVA
7.5.1 CEVA Company Information
7.5.2 CEVA Business Overview
7.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.5.4 CEVA Avian Influenza Vaccines Products Offered
7.5.5 CEVA Recent Development
7.6 Elanco Animal Health
7.6.1 Elanco Animal Health Company Information
7.6.2 Elanco Animal Health Business Overview
7.6.3 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Elanco Animal Health Avian Influenza Vaccines Products Offered
7.6.5 Elanco Animal Health Recent Development
7.7 Zoetis
7.7.1 Zoetis Company Information
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Zoetis Avian Influenza Vaccines Products Offered
7.7.5 Zoetis Recent Development
7.8 FATRO
7.8.1 FATRO Company Information
7.8.2 FATRO Business Overview
7.8.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.8.4 FATRO Avian Influenza Vaccines Products Offered
7.8.5 FATRO Recent Development
7.9 Kyoto Biken
7.9.1 Kyoto Biken Company Information
7.9.2 Kyoto Biken Business Overview
7.9.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Kyoto Biken Avian Influenza Vaccines Products Offered
7.9.5 Kyoto Biken Recent Development
7.10 CAVAC
7.10.1 CAVAC Company Information
7.10.2 CAVAC Business Overview
7.10.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.10.4 CAVAC Avian Influenza Vaccines Products Offered
7.10.5 CAVAC Recent Development
7.11 Ringpu Biology
7.11.1 Ringpu Biology Company Information
7.11.2 Ringpu Biology Business Overview
7.11.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Ringpu Biology Avian Influenza Vaccines Products Offered
7.11.5 Ringpu Biology Recent Development
7.12 Vaksindo
7.12.1 Vaksindo Company Information
7.12.2 Vaksindo Business Overview
7.12.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Vaksindo Avian Influenza Vaccines Products Offered
7.12.5 Vaksindo Recent Development
7.13 Sindh Poultry Vaccine Centre
7.13.1 Sindh Poultry Vaccine Centre Company Information
7.13.2 Sindh Poultry Vaccine Centre Business Overview
7.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Products Offered
7.13.5 Sindh Poultry Vaccine Centre Recent Development
7.14 Merck Animal Health
7.14.1 Merck Animal Health Company Information
7.14.2 Merck Animal Health Business Overview
7.14.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Merck Animal Health Avian Influenza Vaccines Products Offered
7.14.5 Merck Animal Health Recent Development
7.15 PT Medion Farma Jaya
7.15.1 PT Medion Farma Jaya Company Information
7.15.2 PT Medion Farma Jaya Business Overview
7.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Products Offered
7.15.5 PT Medion Farma Jaya Recent Development
7.16 Avimex Animal Health
7.16.1 Avimex Animal Health Company Information
7.16.2 Avimex Animal Health Business Overview
7.16.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Avimex Animal Health Avian Influenza Vaccines Products Offered
7.16.5 Avimex Animal Health Recent Development
7.17 JOVAC
7.17.1 JOVAC Company Information
7.17.2 JOVAC Business Overview
7.17.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.17.4 JOVAC Avian Influenza Vaccines Products Offered
7.17.5 JOVAC Recent Development
7.18 Bio-Labs
7.18.1 Bio-Labs Company Information
7.18.2 Bio-Labs Business Overview
7.18.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Bio-Labs Avian Influenza Vaccines Products Offered
7.18.5 Bio-Labs Recent Development
7.19 Pusvetma
7.19.1 Pusvetma Company Information
7.19.2 Pusvetma Business Overview
7.19.3 Pusvetma Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Pusvetma Avian Influenza Vaccines Products Offered
7.19.5 Pusvetma Recent Development
7.20 IPB-Shigeta
7.20.1 IPB-Shigeta Company Information
7.20.2 IPB-Shigeta Business Overview
7.20.3 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.20.4 IPB-Shigeta Avian Influenza Vaccines Products Offered
7.20.5 IPB-Shigeta Recent Development
7.21 Medion Farma Jaya
7.21.1 Medion Farma Jaya Company Information
7.21.2 Medion Farma Jaya Business Overview
7.21.3 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.21.4 Medion Farma Jaya Avian Influenza Vaccines Products Offered
7.21.5 Medion Farma Jaya Recent Development
7.22 Caprifamarindo
7.22.1 Caprifamarindo Company Information
7.22.2 Caprifamarindo Business Overview
7.22.3 Caprifamarindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Caprifamarindo Avian Influenza Vaccines Products Offered
7.22.5 Caprifamarindo Recent Development
8 Avian Influenza Vaccines Manufacturing Cost Analysis
8.1 Avian Influenza Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Avian Influenza Vaccines
8.4 Avian Influenza Vaccines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Avian Influenza Vaccines Distributors List
9.3 Avian Influenza Vaccines Customers
10 Avian Influenza Vaccines Market Dynamics
10.1 Avian Influenza Vaccines Industry Trends
10.2 Avian Influenza Vaccines Market Drivers
10.3 Avian Influenza Vaccines Market Challenges
10.4 Avian Influenza Vaccines Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
 Table 1. Global Avian Influenza Vaccines Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Avian Influenza Vaccines Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Avian Influenza Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Avian Influenza Vaccines Sales (M Doses) by Region (2020-2025)
 Table 5. Global Avian Influenza Vaccines Sales Market Share by Region (2020-2025)
 Table 6. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Avian Influenza Vaccines Revenue Share by Region (2020-2025)
 Table 8. Global Avian Influenza Vaccines Sales (M Doses) Forecast by Region (2026-2031)
 Table 9. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Avian Influenza Vaccines Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Avian Influenza Vaccines Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Avian Influenza Vaccines Sales by Type (M Doses) & (2020-2025)
 Table 13. Global Avian Influenza Vaccines Sales Share by Type (2020-2025)
 Table 14. Global Avian Influenza Vaccines Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Avian Influenza Vaccines Price by Type (USD/K Doses) & (2020-2025)
 Table 16. Global Avian Influenza Vaccines Sales by Type (M Doses) & (2026-2031)
 Table 17. Global Avian Influenza Vaccines Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Avian Influenza Vaccines Price by Type (USD/K Doses) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Avian Influenza Vaccines Sales by Application (M Doses) & (2020-2025)
 Table 21. Global Avian Influenza Vaccines Sales Share by Application (2020-2025)
 Table 22. Global Avian Influenza Vaccines Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Avian Influenza Vaccines Price by Application (USD/K Doses) & (2020-2025)
 Table 24. Global Avian Influenza Vaccines Sales by Application (M Doses) & (2026-2031)
 Table 25. Global Avian Influenza Vaccines Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Avian Influenza Vaccines Price by Application (USD/K Doses) & (2026-2031)
 Table 27. New Sources of Growth in Avian Influenza Vaccines Application
 Table 28. Global Avian Influenza Vaccines Sales by Company (M Doses) & (2020-2025)
 Table 29. Global Avian Influenza Vaccines Sales Share by Company (2020-2025)
 Table 30. Global Avian Influenza Vaccines Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Avian Influenza Vaccines Revenue Share by Company (2020-2025)
 Table 32. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
 Table 33. Global Market Avian Influenza Vaccines Average Price by Company (USD/K Doses) & (2020-2025)
 Table 34. Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Avian Influenza Vaccines, Product Type & Application
 Table 36. Global Key Manufacturers of Avian Influenza Vaccines, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
 Table 39. North America Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
 Table 40. North America Avian Influenza Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
 Table 42. North America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 43. North America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Table 44. North America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 45. North America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Table 46. Europe Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
 Table 47. Europe Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
 Table 48. Europe Avian Influenza Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
 Table 50. Europe Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 51. Europe Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Table 52. Europe Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 53. Europe Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Table 54. China Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
 Table 55. China Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
 Table 56. China Avian Influenza Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
 Table 58. China Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 59. China Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Table 60. China Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 61. China Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Table 62. Japan Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
 Table 63. Japan Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
 Table 64. Japan Avian Influenza Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Japan Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
 Table 66. Japan Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 67. Japan Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Table 68. Japan Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 69. Japan Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Table 70. South Korea Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
 Table 71. South Korea Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
 Table 72. South Korea Avian Influenza Vaccines Revenue by Company (2020-2025) & (US$ Million)
 Table 73. South Korea Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
 Table 74. South Korea Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 75. South Korea Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Table 76. South Korea Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 77. South Korea Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Table 78. Boehringer Ingelheim Company Information
 Table 79. Boehringer Ingelheim Description and Business Overview
 Table 80. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 81. Boehringer Ingelheim Avian Influenza Vaccines Product
 Table 82. Boehringer Ingelheim Recent Development
 Table 83. CAHIC Company Information
 Table 84. CAHIC Description and Business Overview
 Table 85. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 86. CAHIC Avian Influenza Vaccines Product
 Table 87. CAHIC Recent Development
 Table 88. DHN Company Information
 Table 89. DHN Description and Business Overview
 Table 90. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 91. DHN Avian Influenza Vaccines Product
 Table 92. DHN Recent Development
 Table 93. HVRI Company Information
 Table 94. HVRI Description and Business Overview
 Table 95. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 96. HVRI Avian Influenza Vaccines Product
 Table 97. HVRI Recent Development
 Table 98. CEVA Company Information
 Table 99. CEVA Description and Business Overview
 Table 100. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 101. CEVA Avian Influenza Vaccines Product
 Table 102. CEVA Recent Development
 Table 103. Elanco Animal Health Company Information
 Table 104. Elanco Animal Health Description and Business Overview
 Table 105. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 106. Elanco Animal Health Avian Influenza Vaccines Product
 Table 107. Elanco Animal Health Recent Development
 Table 108. Zoetis Company Information
 Table 109. Zoetis Description and Business Overview
 Table 110. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 111. Zoetis Avian Influenza Vaccines Product
 Table 112. Zoetis Recent Development
 Table 113. FATRO Company Information
 Table 114. FATRO Description and Business Overview
 Table 115. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 116. FATRO Avian Influenza Vaccines Product
 Table 117. FATRO Recent Development
 Table 118. Kyoto Biken Company Information
 Table 119. Kyoto Biken Description and Business Overview
 Table 120. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 121. Kyoto Biken Avian Influenza Vaccines Product
 Table 122. Kyoto Biken Recent Development
 Table 123. CAVAC Company Information
 Table 124. CAVAC Description and Business Overview
 Table 125. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 126. CAVAC Avian Influenza Vaccines Product
 Table 127. CAVAC Recent Development
 Table 128. Ringpu Biology Company Information
 Table 129. Ringpu Biology Description and Business Overview
 Table 130. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 131. Ringpu Biology Avian Influenza Vaccines Product
 Table 132. Ringpu Biology Recent Development
 Table 133. Vaksindo Company Information
 Table 134. Vaksindo Description and Business Overview
 Table 135. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 136. Vaksindo Avian Influenza Vaccines Product
 Table 137. Vaksindo Recent Development
 Table 138. Sindh Poultry Vaccine Centre Company Information
 Table 139. Sindh Poultry Vaccine Centre Description and Business Overview
 Table 140. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 141. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
 Table 142. Sindh Poultry Vaccine Centre Recent Development
 Table 143. Merck Animal Health Company Information
 Table 144. Merck Animal Health Description and Business Overview
 Table 145. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 146. Merck Animal Health Avian Influenza Vaccines Product
 Table 147. Merck Animal Health Recent Development
 Table 148. PT Medion Farma Jaya Company Information
 Table 149. PT Medion Farma Jaya Description and Business Overview
 Table 150. PT Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 151. PT Medion Farma Jaya Avian Influenza Vaccines Product
 Table 152. PT Medion Farma Jaya Recent Development
 Table 153. Avimex Animal Health Company Information
 Table 154. Avimex Animal Health Description and Business Overview
 Table 155. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 156. Avimex Animal Health Avian Influenza Vaccines Product
 Table 157. Avimex Animal Health Recent Development
 Table 158. JOVAC Company Information
 Table 159. JOVAC Description and Business Overview
 Table 160. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 161. JOVAC Avian Influenza Vaccines Product
 Table 162. JOVAC Recent Development
 Table 163. Bio-Labs Company Information
 Table 164. Bio-Labs Description and Business Overview
 Table 165. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 166. Bio-Labs Avian Influenza Vaccines Product
 Table 167. Bio-Labs Recent Development
 Table 168. Pusvetma Company Information
 Table 169. Pusvetma Description and Business Overview
 Table 170. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 171. Pusvetma Avian Influenza Vaccines Product
 Table 172. Pusvetma Recent Development
 Table 173. IPB-Shigeta Company Information
 Table 174. IPB-Shigeta Description and Business Overview
 Table 175. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 176. IPB-Shigeta Avian Influenza Vaccines Product
 Table 177. IPB-Shigeta Recent Development
 Table 178. Medion Farma Jaya Company Information
 Table 179. Medion Farma Jaya Description and Business Overview
 Table 180. Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 181. Medion Farma Jaya Avian Influenza Vaccines Product
 Table 182. Medion Farma Jaya Recent Development
 Table 183. Caprifamarindo Company Information
 Table 184. Caprifamarindo Description and Business Overview
 Table 185. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 186. Caprifamarindo Avian Influenza Vaccines Product
 Table 187. Caprifamarindo Recent Development
 Table 188. Production Base and Market Concentration Rate of Raw Material
 Table 189. Key Suppliers of Raw Materials
 Table 190. Avian Influenza Vaccines Distributors List
 Table 191. Avian Influenza Vaccines Customers List
 Table 192. Avian Influenza Vaccines Market Trends
 Table 193. Avian Influenza Vaccines Market Drivers
 Table 194. Avian Influenza Vaccines Market Challenges
 Table 195. Avian Influenza Vaccines Market Restraints
 Table 196. Research Programs/Design for This Report
 Table 197. Key Data Information from Secondary Sources
 Table 198. Key Data Information from Primary Sources


List of Figures
 Figure 1. Avian Influenza Vaccines Product Picture
 Figure 2. Global Avian Influenza Vaccines Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Avian Influenza Vaccines Sales Market Share by Type in 2024 & 2031
 Figure 4. H5+H7 Avian Influenza Vaccines Product Picture
 Figure 5. H9 Avian Influenza Vaccines Product Picture
 Figure 6. Global Avian Influenza Vaccines Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 7. Global Avian Influenza Vaccines Sales Market Share by Application in 2024 & 2031
 Figure 8. Chicken Examples
 Figure 9. Duck & Goose Examples
 Figure 10. Other Examples
 Figure 11. Global Avian Influenza Vaccines Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Avian Influenza Vaccines Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 13. Global Avian Influenza Vaccines Sales (M Doses) Growth Rate (2020-2031)
 Figure 14. Global Avian Influenza Vaccines Price Trends Growth Rate (2020-2031) & (USD/K Doses)
 Figure 15. Avian Influenza Vaccines Report Years Considered
 Figure 16. Global Market Avian Influenza Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 17. Global Avian Influenza Vaccines Revenue Market Share by Region: 2020 VS 2024
 Figure 18. North America Avian Influenza Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 19. North America Avian Influenza Vaccines Sales (M Doses) Growth Rate (2020-2031)
 Figure 20. Europe Avian Influenza Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 21. Europe Avian Influenza Vaccines Sales (M Doses) Growth Rate (2020-2031)
 Figure 22. China Avian Influenza Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 23. China Avian Influenza Vaccines Sales (M Doses) Growth Rate (2020-2031)
 Figure 24. Japan Avian Influenza Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 25. Japan Avian Influenza Vaccines Sales (M Doses) Growth Rate (2020-2031)
 Figure 26. South Korea Avian Influenza Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 27. South Korea Avian Influenza Vaccines Sales (M Doses) Growth Rate (2020-2031)
 Figure 28. Global Avian Influenza Vaccines Revenue Share by Type (2020-2025)
 Figure 29. Global Avian Influenza Vaccines Sales Share by Type (2026-2031)
 Figure 30. Global Avian Influenza Vaccines Revenue Share by Type (2026-2031)
 Figure 31. Global Avian Influenza Vaccines Revenue Share by Application (2020-2025)
 Figure 32. Global Avian Influenza Vaccines Revenue Growth Rate by Application in 2020 & 2024
 Figure 33. Global Avian Influenza Vaccines Sales Share by Application (2026-2031)
 Figure 34. Global Avian Influenza Vaccines Revenue Share by Application (2026-2031)
 Figure 35. Global Avian Influenza Vaccines Sales Share by Company (2024)
 Figure 36. Global Avian Influenza Vaccines Revenue Share by Company (2024)
 Figure 37. Global 5 Largest Avian Influenza Vaccines Players Market Share by Revenue in Avian Influenza Vaccines: 2020 & 2024
 Figure 38. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 39. Manufacturing Cost Structure of Avian Influenza Vaccines
 Figure 40. Manufacturing Process Analysis of Avian Influenza Vaccines
 Figure 41. Avian Influenza Vaccines Industrial Chain
 Figure 42. Channels of Distribution (Direct Vs Distribution)
 Figure 43. Distributors Profiles
 Figure 44. Bottom-up and Top-down Approaches for This Report
 Figure 45. Data Triangulation
 Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS